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rAtrial fibrillation (AF) is the most common
cardiac arrhythmia (1) with significant morbidity
and mortality (2). A significant milestone in the
treatment of AF was achieved by introducing
catheter-based ablation (3–5). For the last decade
various approaches and technologies have evolved
aimed at improving and refining the ablative
treatment of AF.
See page 308
Electrical isolation of pulmonary veins with ra-
diofrequency (RF) ablation has now been widely
accepted for treatment of AF in which single
antiarrhythmic medication has failed (6). RF has
also been shown to maintain long-term sinus
rhythm in chronic AF (7). Isolation of pulmonary
veins with RF catheter ablation of pulmonary veins
has an encouraging success rate (7,8). The recur-
rence of AF has been associated with incomplete
pulmonary vein isolation and the existence of trig-
gers beyond the pulmonary veins (9,10). Despite
many exciting novel approaches, electrical isolation
of the pulmonary veins by applying circumferential
lesions around their antra remains the most widely
accepted ablation strategy.
Multiple ablation technologies, modalities, and
energy sources have also been studied to achieve 2
main goals: delivery of an appropriate transmural
lesion to avoid recurrent arrhythmias and collateral
damage post-ablation and improvement of navi-
gation within the left atrial cavity to facilitate
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From the Atrial Fibrillation Program and Electrophysiology Laboratory,
Division of Cardiology, University of Utah, Salt Lake City, Utah.doption of the procedure in the electrophysiol-
gy (EP) lab. In this issue of iJACC, Peters et al.
11) describe an interesting imaging modality
ased on 3-dimensional delayed-enhancement
ardiac magnetic resonance (CMR) to track abla-
ion lesions post-ablation of AF in an elegantly
onducted study. The authors confirm findings
rom our group that suggest that more lesions
orrelate with better outcome (12). Thirteen (37%)
atients had recurrent AF during the 6.7  3.6
onth observation period. The volume of scar in
he right inferior pulmonary vein (RIPV) was quan-
itatively greater in patients without recurrence (p
.049). Qualitatively, patients without recurrence
ad more circumferentially scarred veins (p 
.036). They use the expression “lynch pin” to
xpress their findings. The RIPV is always a major
hallenge during an ablation procedure. This could
e attributed to its vicinity to the transseptal punc-
ure site that might lead to impaired tissue catheter
nterface and stability of the ablation catheter dur-
ng ablation. The authors also describe merging the
-dimensional lesions model with the pre-acquired
-dimensional CMR model. This would be a help-
ul tool to locate the site of the lesions, but it might
ave been more accurate if the lesions were seg-
ented as a part of the left atrial tissue as described
y McGann et al. (12). Although this study shows
car volume of RIPV isolation predicts recurrence,
hese results must be interpreted with caution due
o the small sample size.
In the last decade, a great deal of effort has been
nvested in improving tools and imaging modalities
hat would help navigation within the left atrial
hamber (13,14). Recently Nazarian et al. (15)
eported the feasibility of real-time CMR-guided
P procedures (15) and Dukkipati et al. (16)
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318described a novel electroanatomical mapping
CMR-guided EP procedure. Until recently, no
major focus has been dedicated toward detection
and monitoring of left atrial tissue damage acquired
during ablation. Our group and others recently
introduced 3-dimensional CMR-based methods to
detect and monitor lesions after an AF ablation
procedure (11,12,17). The visualization of left atrial
lesion formation and depth as it forms represents an
important first step on the road to “real-time CMRlege of Cardiology (ACC) American
Heart Association (AHA). HRS/
1
1
study. J Am Coll C
2:308–16.also be furthered by the interdisciplinary coopera-
tion between radiologists and electrophysiologists.
Such a model has already proven successful at our,
and many other, institutions.
Reprint requests and correspondence: Dr. Nassir F. Mar-
ouche, Atrial Fibrillation Program and Electrophysiol-
gy Laboratory, Division of Cardiology, University of
tah Health Sciences Center, 30 North 1900 East,
oom 4A100, Salt Lake City, Utah 84132. E-mail:for AF ablation.” Achievement of this goal would nassir.marrouche@hsc.utah.edu.R E F E R E N C E S
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